VIEMED HEALTHCARE INC
For the period ended Dec 31, 2023. Filed Mar 6, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Mar 6, 2024
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 16. Form 10-K Summary
None.
| Page | 47 |
VIEMED HEALTHCARE, INC.
(Tabular dollar amounts expressed in thousands of U.S. Dollars, except per share amounts)
December 31, 2023 and 2022
SIGNATURES
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| VIEMED HEALTHCARE, INC. | |
| (Registrant) | |
| By: | /s/ Casey Hoyt |
| Casey Hoyt | |
| Chief Executive Officer | |
| By: | /s/ Trae Fitzgerald |
| Trae Fitzgerald | |
| Chief Financial Officer |
Date: March 6, 2024
Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.
| Signature | Title | Date |
|---|---|---|
| /s/ Casey Hoyt | Chief Executive Officer and Director | March 6, 2024 |
| Casey Hoyt | (Principal Executive Officer) | |
| /s/ Trae Fitzgerald | Chief Financial Officer | March 6, 2024 |
| Trae Fitzgerald | (Principal Financial Officer and Accounting Officer) | |
| /s/ W. Todd Zehnder | Chief Operating Officer and Director | March 6, 2024 |
| W. Todd Zehnder | ||
| /s/ Randy Dobbs | Chairman of the Board of Directors | March 6, 2024 |
| Randy Dobbs | ||
| /s/ Dr. William Frazier | Director and Chief Medical Officer | March 6, 2024 |
| Dr. William Frazier | ||
| /s/ Bruce Greenstein | Director | March 6, 2024 |
| Bruce Greenstein | ||
| /s/ Sabrina Heltz | Director | March 6, 2024 |
| Sabrina Heltz | ||
| /s/ Nitin Kaushal | Director | March 6, 2024 |
| Nitin Kaushal | ||
| /s/ Timothy Smokoff | Director | March 6, 2024 |
| Timothy Smokoff | ||
| Page | 48 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.